Make the switch to QCI Interpret, the industry's most trusted clinical bioinformatics platform—used to analyze and interpret more than 3.5 million NGS patient test cases worldwide.
TRUST & CONFIDENCE
With over 3.5 million NGS patient test cases analyzed and interpreted worldwide, QCI Interpret is one of the most widely used and universally respected platforms for efficiently accessing clinical evidence to support confident decision-making in genetic testing.
EXPERIENCE & STABILITY
QCI Interpret is currently growing at 35% or 700,000 additional cases per annum, outperforming other commercial offerings by a factor 5 in terms of patient cases.
WHITE GLOVE SUPPORT
Receive dedicated support from our Field Application Scientist team, who is highly specialized in the field of clinical genetics, to help you onboard, customize, and scale your new platform and pipeline.
What are our customers saying?
QCI Interpret is clinical decision support software that combines the unmatched accuracy and consistency of QIAGEN’s proprietary expert (MD/PhD) curation with the superior efficiency of machine curation (AI-powered curation) to enable high-confidence variant interpretation and reporting. Advanced features enable clinical diagnostic labs to rapidly identify pathogenic variants, improve diagnostic yields, and reduce turnaround times.
Agnostic - The flexible software is platform- and sequencer-agnostic to provide an end-to-end VCF to report solution.
Advanced curation - The software provides AI-derived literature references for thousands of additional genes in the clinical genome to supplement QIAGEN’s expert, human-certified curation.
AI-enabled - The software uses AI-trained phenotype-driven ranking, in which an algorithm uses observed patient phenotypes to prioritize diseases and genes to expedite causal-variant discovery.
Automated - The software automatically and transparently computes ACMG/AMP variant classifications with evidence to trigger all 28 criteria.
Accurate reporting - Users can quickly generate custom, patient-specific reports with the latest diagnostic, prognostic, and therapeutic information.
Annual releases - QCI Interpret is continuously updated and optimized with annual software releases that ensure long-term performance and usability.
If you are a current user of HGMD Professional, enhance your workflow by upgrading to QCI Interpret. The software provides more features, greater functionality and even richer content for accurate and efficient variant interpretation and reporting.
VCF to Report - QCI Interpret provides an integrated and automated workflow from VCF to final report.
Automated variant classification - QCI Interpret returns evidence categorized into one of the 28 defined criteria set forth by the ACMG/AMP guidelines and assigns a calculated strength of the evidence.
Comprehensive curation - QCI Interpret provides deeper evidence curation, including clinical professional guidelines, clinical and genomic studies, and clinical trials and therapies.
LIVE WEBINAR: NOVEMBER 7, 2023
Eager to learn more? Attend our expert webinar on November 7, 2023, for a live demonstraton of the unique features in QCI Interpret for Oncology. Plus, learn about QCI Interpret's new capabilities that further enhance the platform’s scalability and flexibility, and enables users to significantly reduce variant research and review time.
We understand the challenge of selecting and onboarding a new clinical informatics platform to replace your Alissa software. However, QCI Interpret offers the same features of Alissa, but provides deeper and richer content to support confident variant interpretation and reporting.
Take the first step. Our dedicated support team is ready to show you how QCI Interpret can not only replace your Alissa platform, but take your variant interpretation and reporting pipeline to the next level.